Cell Cycle Ontology

Last uploaded: June 26, 2014
Preferred Name

Maple syrup urine disease

Synonyms

Maple syrup urine disease 1B

Maple syrup urine disease 1A

Maple syrup urine disease 2

Definitions

(MSUD): A metabolic disorder due to an enzyme defect in the catabolic pathway of the branched-chain amino acids leucine, isoleucine, and valine. Accumulation of these 3 amino acids and their corresponding keto acids leads to encephalopathy and progressive neurodegeneration. Clinical features include mental and physical retardation, feeding problems, and a maple syrup odor to the urine. The keto acids of the branched-chain amino acids are present in the urine. If untreated, maple syrup urine disease can lead to seizures, coma, and death. The disease is often classified by its pattern of signs and symptoms. The most common and severe form of the disease is the classic type, which becomes apparent soon after birth. Variant forms of the disorder become apparent later in infancy or childhood and are typically milder, but they still involve developmental delay and other medical problems if not treated.(MSUD1A): A metabolic disorder due to an enzyme defect in the catabolic pathway of the branched-chain amino acids leucine, isoleucine, and valine. Accumulation of these 3 amino acids and their corresponding keto acids leads to encephalopathy and progressive neurodegeneration. Clinical features include mental and physical retardation, feeding problems, and a maple syrup odor to the urine. The keto acids of the branched-chain amino acids are present in the urine. If untreated, maple syrup urine disease can lead to seizures, coma, and death. The disease is often classified by its pattern of signs and symptoms. The most common and severe form of the disease is the classic type, which becomes apparent soon after birth. Variant forms of the disorder become apparent later in infancy or childhood and are typically milder, but they still involve developmental delay and other medical problems if not treated.(MSUD1B): A metabolic disorder due to an enzyme defect in the catabolic pathway of the branched-chain amino acids leucine, isoleucine, and valine. Accumulation of these 3 amino acids and their corresponding keto acids leads to encephalopathy and progressive neurodegeneration. Clinical features include mental and physical retardation, feeding problems, and a maple syrup odor to the urine. The keto acids of the branched-chain amino acids are present in the urine. If untreated, maple syrup urine disease can lead to seizures, coma, and death. The disease is often classified by its pattern of signs and symptoms. The most common and severe form of the disease is the classic type, which becomes apparent soon after birth. Variant forms of the disorder become apparent later in infancy or childhood and are typically milder, but they still involve developmental delay and other medical problems if not treated.(MSUD2): A metabolic disorder due to an enzyme defect in the catabolic pathway of the branched-chain amino acids leucine, isoleucine, and valine. Accumulation of these 3 amino acids and their corresponding keto acids leads to encephalopathy and progressive neurodegeneration. Clinical features include mental and physical retardation, feeding problems, and a maple syrup odor to the urine. The keto acids of the branched-chain amino acids are present in the urine. If untreated, maple syrup urine disease can lead to seizures, coma, and death. The disease is often classified by its pattern of signs and symptoms. The most common and severe form of the disease is the classic type, which becomes apparent soon after birth. Variant forms of the disorder become apparent later in infancy or childhood and are typically milder, but they still involve developmental delay and other medical problems if not treated.

ID

http://purl.obolibrary.org/obo/OMIM_248600

definition

(MSUD): A metabolic disorder due to an enzyme defect in the catabolic pathway of the branched-chain amino acids leucine, isoleucine, and valine. Accumulation of these 3 amino acids and their corresponding keto acids leads to encephalopathy and progressive neurodegeneration. Clinical features include mental and physical retardation, feeding problems, and a maple syrup odor to the urine. The keto acids of the branched-chain amino acids are present in the urine. If untreated, maple syrup urine disease can lead to seizures, coma, and death. The disease is often classified by its pattern of signs and symptoms. The most common and severe form of the disease is the classic type, which becomes apparent soon after birth. Variant forms of the disorder become apparent later in infancy or childhood and are typically milder, but they still involve developmental delay and other medical problems if not treated.(MSUD1A): A metabolic disorder due to an enzyme defect in the catabolic pathway of the branched-chain amino acids leucine, isoleucine, and valine. Accumulation of these 3 amino acids and their corresponding keto acids leads to encephalopathy and progressive neurodegeneration. Clinical features include mental and physical retardation, feeding problems, and a maple syrup odor to the urine. The keto acids of the branched-chain amino acids are present in the urine. If untreated, maple syrup urine disease can lead to seizures, coma, and death. The disease is often classified by its pattern of signs and symptoms. The most common and severe form of the disease is the classic type, which becomes apparent soon after birth. Variant forms of the disorder become apparent later in infancy or childhood and are typically milder, but they still involve developmental delay and other medical problems if not treated.(MSUD1B): A metabolic disorder due to an enzyme defect in the catabolic pathway of the branched-chain amino acids leucine, isoleucine, and valine. Accumulation of these 3 amino acids and their corresponding keto acids leads to encephalopathy and progressive neurodegeneration. Clinical features include mental and physical retardation, feeding problems, and a maple syrup odor to the urine. The keto acids of the branched-chain amino acids are present in the urine. If untreated, maple syrup urine disease can lead to seizures, coma, and death. The disease is often classified by its pattern of signs and symptoms. The most common and severe form of the disease is the classic type, which becomes apparent soon after birth. Variant forms of the disorder become apparent later in infancy or childhood and are typically milder, but they still involve developmental delay and other medical problems if not treated.(MSUD2): A metabolic disorder due to an enzyme defect in the catabolic pathway of the branched-chain amino acids leucine, isoleucine, and valine. Accumulation of these 3 amino acids and their corresponding keto acids leads to encephalopathy and progressive neurodegeneration. Clinical features include mental and physical retardation, feeding problems, and a maple syrup odor to the urine. The keto acids of the branched-chain amino acids are present in the urine. If untreated, maple syrup urine disease can lead to seizures, coma, and death. The disease is often classified by its pattern of signs and symptoms. The most common and severe form of the disease is the classic type, which becomes apparent soon after birth. Variant forms of the disorder become apparent later in infancy or childhood and are typically milder, but they still involve developmental delay and other medical problems if not treated.

has_obo_namespace

cell_cycle_ontology

has_related_synonym

Maple syrup urine disease 1B

Maple syrup urine disease 1A

Maple syrup urine disease 2

id

OMIM:248600

label

Maple syrup urine disease

notation

OMIM:248600

prefLabel

Maple syrup urine disease

treeView

http://purl.obolibrary.org/obo/OGMS_0000031

subClassOf

http://purl.obolibrary.org/obo/OGMS_0000031

Delete Subject Author Type Created
No notes to display
Create mapping

Delete Mapping To Ontology Source
rgo:07571 GAMUTS LOOM
http://purl.obolibrary.org/obo/MONDO_0009563 EFO LOOM
http://purl.obolibrary.org/obo/DOID_9269 CLO LOOM
http://purl.obolibrary.org/obo/DOID_9269 DOID LOOM
http://purl.obolibrary.org/obo/DOID_9269 DDSS LOOM
http://purl.obolibrary.org/obo/MONDO_0009563 MONDO LOOM
http://www.orpha.net/ORDO/Orphanet_511 ORDO LOOM
http://www.limics.org/hrdo/rdfns#pat_id_708 HRDO LOOM
http://nanbyodata.jp/ontology/NANDO_1200791 NANDO LOOM
http://nanbyodata.jp/ontology/NANDO_2200473 NANDO LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#C16.320.565.189.520 RH-MESH LOOM
http://www.orpha.net/ORDO/Orphanet_511 ORDO LOOM
http://purl.bioontology.org/ontology/LNC/LA21168-2 LOINC LOOM
http://purl.jp/bio/4/id/200906010796288126 IOBC LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#C18.452.648.189.520 RH-MESH LOOM
http://purl.bioontology.org/ontology/LNC/MTHU021578 LOINC LOOM
http://purl.obolibrary.org/obo/OMIT_0009446 OMIT LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#D008375 RH-MESH LOOM
http://www.owl-ontologies.com/NPOntology.owl#DOID_9269 NATPRO LOOM
http://purl.bioontology.org/ontology/ICD10/E71.0 ICD10 LOOM
http://purl.bioontology.org/ontology/MEDLINEPLUS/C0024776 MEDLINEPLUS LOOM
http://www.phoc.org.cn/pmo/class/PMO_00038500 PMAPP-PMO LOOM
http://sbmi.uth.tmc.edu/ontology/ochv#7741 OCHV LOOM
http://purl.bioontology.org/ontology/SNOMEDCT/27718001 SNOMEDCT LOOM
http://www.owl-ontologies.com/unnamed.owl#RID15092 DERMLEX LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#C18.452.648.100.608 RH-MESH LOOM
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#Maple_Syrup_Urine_Disease CSEO LOOM
http://purl.bioontology.org/ontology/MEDDRA/10026818 MEDDRA LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#C10.228.140.163.100.520 RH-MESH LOOM
http://purl.bioontology.org/ontology/LNC/LP56746-8 LOINC LOOM
http://purl.obolibrary.org/obo/MONDO_0009563 DOVES LOOM
http://purl.obolibrary.org/obo/DOID_9269 DTO LOOM
http://purl.obolibrary.org/obo/DOID_9269 BAO LOOM
http://purl.obolibrary.org/obo/DOID_9269 HHEAR LOOM
http://purl.obolibrary.org/obo/DOID_9269 NIFSTD LOOM
http://purl.obolibrary.org/obo/DOID_9269 FNS-H LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#C16.320.565.100.608 RH-MESH LOOM
http://www.semanticweb.org/rjyy/ontologies/2015/5/ESSO#Maple_Syrup_Urine_Disease ESSO LOOM
http://www.semanticweb.org/rjyy/ontologies/2015/5/ESSO#Maple_Syrup_Urine_Disease MEPO LOOM
http://www.semanticweb.org/rjyy/ontologies/2015/5/ESSO#Maple_Syrup_Urine_Disease EPISEM LOOM
http://purl.bioontology.org/ontology/OMIM/248600 OMIM LOOM
http://purl.bioontology.org/ontology/CSP/1849-1063 CRISP LOOM
http://sbmi.uth.tmc.edu/ontology/ochv#C0024776 OCHV LOOM
http://purl.bioontology.org/ontology/RCD/C3033 RCD LOOM
http://purl.bioontology.org/ontology/MESH/D008375 MESH LOOM
http://purl.bioontology.org/ontology/RCTV2/C303300 RCTV2 LOOM
http://purl.bioontology.org/ontology/ICD10CM/E71.0 ICD10CM LOOM
http://purl.obolibrary.org/obo/NCIT_C34806 BERO LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#C18.452.132.100.520 RH-MESH LOOM
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C34806 NCIT LOOM
http://www.owl-ontologies.com/Ontology1358660052.owl#Maple_Syrup_Urine_Disease PEDTERM LOOM